Scarica l'app Stockscreener
46.18
0.67%
-0.31
Dopo l'orario di chiusura:
46.00
-0.18
-0.39%
Precedente Chiudi:
$46.49
Aprire:
$46.67
Volume 24 ore:
4.27M
Relative Volume:
0.77
Capitalizzazione di mercato:
$8.29B
Reddito:
$1.36B
Utile/perdita netta:
$-302.91M
Rapporto P/E:
-26.88
EPS:
-1.7182
Flusso di cassa netto:
$-219.93M
1 W Prestazione:
+5.12%
1M Prestazione:
-16.81%
6M Prestazione:
-34.30%
1 anno Prestazione:
-22.06%
Intervallo 1D:
$45.84
$47.77
Intervallo di 1 settimana:
$42.62
$47.77
Portata 52W:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Underperform |
| 2026-04-13 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Tempus AI, Inc. (TEM) Stock Analysis: A Balanced Look At Its 45% Potential Upside - DirectorsTalk Interviews
Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology Algorithm - Insider Monkey
Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic Partnership - Insider Monkey
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Tempus AI (NASDAQ: TEM) investors choose 3-year say-on-pay cycle - Stock Titan
Tempus AI Stock (TEM) Opinions on Fund Holdings and Trading Strategies - Quiver Quantitative
Tempus AI: Taking Advantage Of Investor Myopia (NASDAQ:TEM) - Seeking Alpha
Tempus releases digital test for prostate cancer prognosis - Crain's Chicago Business
TEM Stock Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI Insiders Sold Shares Worth Over $1.5M - TradingView
Tempus AI (TEM) Diagnostics CEO sells 1,580 shares for RSU tax withholding - Stock Titan
Tempus AI (TEM) CFO’s mandated share sale covers RSU tax obligations - Stock Titan
Tempus AI (TEM) legal chief’s non-discretionary tax sell-to-cover trade - Stock Titan
Tempus AI (TEM) CEO Lefkofsky sells 22,335 shares to cover RSU taxes - Stock Titan
Tempus AI (TEM) executive logs 13,550-share tax sell-to-cover transaction - Stock Titan
Tempus AI (TEM) CAO executes mandatory sell-to-cover for RSU taxes - Stock Titan
Tempus AI Launches AI Powered Prostate Cancer Risk Test - Moomoo
Tempus launches AI prostate cancer test on its platform - Investing.com UK
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use - Yahoo Finance
1TEM.MI Stock Price, Quote & Chart | TEMPUS AI INC-CL A (BIT:1TEM) - ChartMill
TEM (NASDAQ: TEM) director reports sale of 2,902 shares for $171K - Stock Titan
James W. Rogers sells 21,498 shares at TEM (NASDAQ: TEM) - Stock Titan
[144] Tempus AI, Inc. SEC Filing - Stock Titan
TEM (NASDAQ: TEM) notice: insider plans to sell RSU-derived Class A shares - Stock Titan
TEM (NASDAQ: TEM) Rule 144 lists RSUs and two 10b5-1 sales by Andrew Polovin - Stock Titan
Eric Lefkofsky sells TEM (NASDAQ: TEM) Class A shares reported in Form 144 - Stock Titan
TEM (NASDAQ: TEM) affiliate seeks to sell 9,592 Class A shares for $566K - Stock Titan
Long term debt to total assets ratio of Tempus AI, Inc. Class A – HAM:F3M - TradingView
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery - Benzinga
ETFs Investing in Tempus AI, Inc. Class A Stocks - TradingView
Price to sales ratio of Tempus AI, Inc. Class A – HAM:F3M - TradingView
Cash per share of Tempus AI, Inc. Class A – HAM:F3M - TradingView
Tempus AI, Inc. Class A Trade Ideas — HAM:F3M - TradingView
InvestingPro spotted Tempus AI’s 40% decline months in advance By Investing.com - Investing.com
Tempus AI Earnings Call Highlights Data-Driven Growth - TipRanks
TEM Technical Analysis | Trend, Signals & Chart Patterns | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
4 Heavily Shorted AI Stocks to Watch Right Now - Schaeffer's Investment Research
Piper Sandler Maintains Tempus AI (TEM) Neutral Recommendation - MSN
US88023BAG8 Bond Analysis — Key Metrics - TradingView
AI in cardiology set to grow as Tempus projects $1.59B 2026 sales - Stock Titan
Assessing Tempus AI (TEM) Valuation After Recent Share Price Weakness - Yahoo Finance
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts - Yahoo Finance
ARK Invest Increases AI and Genomic Holdings While Reducing Semi - GuruFocus
Tempus AI And BMS Deepen AI Drug Development Ties As Losses Persist - Yahoo Finance
How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here - Barchart
7 Healthcare AI Stocks Under $50 With Huge Upside Potential - 24/7 Wall St.
Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM (ARKK:BATS) - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
Tempus AI stock gains following the ALERT trial result announcement - MSN
Tempus AI stock jumps, ALERT trial results boost EHR automation buzz - MSN
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):